• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

长春瑞滨外渗导致的皮肤坏死。

Skin necrosis from extravasation of vinorelbine.

作者信息

Moreno de Vega M J, Dauden E, Abajo P, Bartolome B, Fraga J, Garcia-Diez A

机构信息

Department of Dermatology, Hospital Universitario de la Princesa, Madrid, Spain.

出版信息

J Eur Acad Dermatol Venereol. 2002 Sep;16(5):488-90. doi: 10.1046/j.1468-3083.2002.00564.x.

DOI:10.1046/j.1468-3083.2002.00564.x
PMID:12428844
Abstract

Skin necrosis from intravenous infiltration of soft tissue is a rare but potentially devastating complication of intravenous therapy. Vinca alkaloids are among the intravenous drugs with the highest destructive power. We report two cases of skin necrosis from accidental extravasation of vinorelbine, a semisynthetic analogue of vinblastine, rarely described as being responsible for this event. Histopathologic study showed separation of the dermis from necrotic epidermis, associated with cytologic atypia, in both patients, and focal necrosis of eccrine glands in one of them. We consider that intravenous infusions of vinorelbine should be performed using the preventive measures and care applied for other chemotherapeutic agents with high potential for induction of skin necrosis due to extravasation.

摘要

软组织静脉内浸润导致的皮肤坏死是静脉治疗中一种罕见但可能具有毁灭性的并发症。长春花生物碱是具有最高破坏力的静脉用药之一。我们报告了两例因长春瑞滨意外外渗导致皮肤坏死的病例,长春瑞滨是长春碱的半合成类似物,很少被描述为导致这一事件的原因。组织病理学研究显示,两名患者的真皮与坏死表皮分离,并伴有细胞异型性,其中一名患者的汗腺有局灶性坏死。我们认为,输注长春瑞滨时应采取预防措施并给予护理,这些措施适用于其他因外渗而有高诱导皮肤坏死可能性的化疗药物。

相似文献

1
Skin necrosis from extravasation of vinorelbine.长春瑞滨外渗导致的皮肤坏死。
J Eur Acad Dermatol Venereol. 2002 Sep;16(5):488-90. doi: 10.1046/j.1468-3083.2002.00564.x.
2
Two case reports of vinorelbine extravasation: management and review of the literature.长春瑞滨外渗的两例病例报告:处理及文献综述
Tumori. 2000 Jul-Aug;86(4):289-92. doi: 10.1177/030089160008600406.
3
[The incidence of phlebitis in the patients administrated vinorelbine by intravenous bolus injection--a retrospective study].[静脉推注长春瑞滨患者静脉炎的发生率——一项回顾性研究]
Gan To Kagaku Ryoho. 2002 Apr;29(4):633-5.
4
[Oral vinorelbine: pharmacology and treatment outcome in non-small cell bronchial carcinoma and breast carcinoma].口服长春瑞滨:非小细胞支气管癌和乳腺癌的药理学及治疗结果
Onkologie. 2006 Mar;29 Suppl 1:1-28. doi: 10.1159/000091889. Epub 2006 Mar 3.
5
Respiratory failure following vinorelbine tartrate infusion in a patient with non-small cell lung cancer.
Chest. 1997 Sep;112(3):846-8. doi: 10.1378/chest.112.3.846.
6
[Antineoplastic drug-induced extravasation].[抗肿瘤药物引起的外渗]
Med Klin (Munich). 2010 Nov;105(11):812-24. doi: 10.1007/s00063-010-1139-y.
7
Vinorelbine-induced chemotherapy port extravasation.长春瑞滨所致化疗药物经静脉留置针外渗
Lancet Oncol. 2016 Dec;17(12):e568. doi: 10.1016/S1470-2045(16)30556-3.
8
Vinorelbine-associated myelopathy in a patient who previously received paclitaxel: a case report.
Med Oncol. 2001;18(1):95-7. doi: 10.1385/MO:18:1:95.
9
Combination docetaxel/vinorelbine for metastatic breast cancer and non-small-cell lung cancer.多西他赛/长春瑞滨联合用于转移性乳腺癌和非小细胞肺癌。
Oncology (Williston Park). 1997 Aug;11(8 Suppl 8):46-9.
10
Randomized trial of drip infusion versus bolus injection of vinorelbine for the control of local venous toxicity.长春瑞滨静脉滴注与大剂量注射控制局部静脉毒性的随机试验。
Lung Cancer. 2007 Mar;55(3):337-41. doi: 10.1016/j.lungcan.2006.10.016. Epub 2006 Nov 28.

引用本文的文献

1
Eccrine Squamous Syringometaplasia Associated with Pelubiprofen Therapy.与吡罗昔康治疗相关的小汗腺鳞状化生
Ann Dermatol. 2017 Jun;29(3):334-336. doi: 10.5021/ad.2017.29.3.334. Epub 2017 May 11.
2
Use of totally implantable central venous access port via the basilic vein in patients with thoracic malignancies.经贵要静脉置入全植入式中心静脉通路端口在胸部恶性肿瘤患者中的应用
Int J Clin Oncol. 2009 Jun;14(3):208-12. doi: 10.1007/s10147-008-0835-6. Epub 2009 Jul 11.